NAS:DXCM (USA)
Business Description
DexCom Inc
NAICS : 325413
SIC : 5047
6340 Sequence Drive, San Diego, CA, USA, 92121
Description
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.29 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.95 | |||||
Debt-to-EBITDA | 5.52 | |||||
Interest Coverage | 3.82 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 8.52 | |||||
Beneish M-Score | -2.5 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 27.9 | |||||
3-Year FCF Growth Rate | -5.8 | |||||
3-Year Book Growth Rate | 46.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Industry Rank | 10.27 | |||||
Future 3-5Y Total Revenue Growth Rate Industry Rank | 17.76 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.58 | |||||
9-Day RSI | 65.17 | |||||
14-Day RSI | 62.87 | |||||
6-1 Month Momentum % | -25.34 | |||||
12-1 Month Momentum % | -40.1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.72 | |||||
Quick Ratio | 4.3 | |||||
Cash Ratio | 3.41 | |||||
Days Inventory | 137.7 | |||||
Days Sales Outstanding | 71.87 | |||||
Days Payable | 75.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.5 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 66.1 | |||||
Operating Margin % | 8.87 | |||||
Net Margin % | 7.47 | |||||
ROE % | 9.22 | |||||
ROA % | 4.09 | |||||
ROIC % | 16.43 | |||||
ROC (Joel Greenblatt) % | 21.36 | |||||
ROCE % | 5.99 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 189.73 | |||||
Forward PE Ratio | 115.09 | |||||
PE Ratio without NRI | 189.73 | |||||
Shiller PE Ratio | 783.36 | |||||
Price-to-Owner-Earnings | 281.68 | |||||
PS Ratio | 14.12 | |||||
PB Ratio | 15.88 | |||||
Price-to-Tangible-Book | 16.27 | |||||
Price-to-Free-Cash-Flow | 171.87 | |||||
Price-to-Operating-Cash-Flow | 62.82 | |||||
EV-to-EBIT | 141.08 | |||||
EV-to-Forward-EBIT | 80.68 | |||||
EV-to-EBITDA | 90.85 | |||||
EV-to-Forward-EBITDA | 56 | |||||
EV-to-Revenue | 13.17 | |||||
EV-to-Forward-Revenue | 11.81 | |||||
EV-to-FCF | 159.43 | |||||
Price-to-Projected-FCF | 11.82 | |||||
Price-to-Median-PS-Value | 0.95 | |||||
Price-to-Graham-Number | 11.72 | |||||
Price-to-Net-Current-Asset-Value | 42.26 | |||||
Earnings Yield (Greenblatt) % | 0.71 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:DXCM
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2,673.4 | ||
EPS (TTM) ($) | 0.481 | ||
Beta | 1.02 | ||
Volatility % | 51.73 | ||
14-Day RSI | 62.87 | ||
14-Day ATR ($) | 3.841398 | ||
20-Day SMA ($) | 82.86875 | ||
12-1 Month Momentum % | -40.1 | ||
52-Week Range ($) | 66.8925 - 164.86295 | ||
Shares Outstanding (Mil) | 392.58 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
DexCom Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |